-
, shaping the future of medicine through cutting-edge research. The Department of Integrative Translational Sciences at City of Hope comprises a diverse team of biologists, data scientists, engineers
-
clinical setting Your qualifications should include: · Ph.D. degree chemistry, biochemistry, structural biology, biophysics or a related discipline is required. · Knowledge of protein engineering
-
edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate, you will: · Manufacture
-
-paced lab involved in cutting edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate
-
, including first-in-human studies with genetically engineered hematopoietic stem and progenitor cells (HSPC) and T cells. As a successful candidate, you will: · Conduct research on next-generation
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and
-
leukemogenesis as well as disease relapse in order to design novel inhibitors to intervene the malignancies · Collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology
-
and identification of HLA-restricted epitopes derived from them As a successful candidate, you will: · Work with both genetically engineered mouse models, patient-derived AML xenograft models
-
. For more information on Dr. Schones’ research please visit here . · PhD or M.D. in biology, computer science, biomedical engineering, physics or other related discipline. · Excellent
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and